Suchbegriffe: PROSTATIC NEOPLASMS - EPIDEMIOLOGY , . Treffer: 5
Langsenlehner, T; Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Gerger, A; Pichler, M
Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients.
World J Urol. 2015; 33(11):1661-1667
Doi: 10.1007/s00345-015-1494-7
Web of Science
PubMed
FullText
FullText_MUG
Auprich, M; Haese, A; Walz, J; Pummer, K; de la Taille, A; Graefen, M; de Reijke, T; Fisch, M; Kil, P; Gontero, P; Irani, J; Chun, FKH
External Validation of Urinary PCA3-Based Nomograms to Individually Predict Prostate Biopsy Outcome.
EUR UROL. 2010; 58(5): 727-732.
Doi: 10.1016/j.eururo.2010.06.038
Web of Science
PubMed
FullText
FullText_MUG
Bhojani, N; Perrotte, P; Jeldres, C; Suardi, N; Hutterer, G; Shariat, SF; Karakiewicz, PI
The effect of comorbidities and socioeconomic status on sexual and urinary function in men undergoing prostate cancer screening.
J Sex Med. 2008; 5(3):668-676
Doi: 10.1111/j.1743-6109.2007.00722.x
Web of Science
PubMed
FullText
FullText_MUG
Gallina, A; Chun, FK; Suardi, N; Eastham, JA; Perrotte, P; Graefen, M; Hutterer, G; Huland, H; Klein, EA; Reuther, A; Montorsi, F; Briganti, A; Shariat, SF; Roehrborn, CG; de la Taille, A; Salomon, L; Karakiewicz, PI
Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.
BJU Int. 2008; 101(12):1513-1518
Doi: 10.1111/j.1464-410X.2008.07519.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schmid, HP; Engeler, DS; Pummer, K; Schmitz-Dräger, BJ
Prevention of prostate cancer: more questions than data.
Recent Results Cancer Res. 2007; 174(2): 101-107.
Doi: 10.1007/978-3-540-37696-5_10
PubMed
FullText
FullText_MUG